[go: up one dir, main page]

WO2014045072A3 - Deuterium depleted water and/or deuterium-depleted organic compound for the treatment of hypertension - Google Patents

Deuterium depleted water and/or deuterium-depleted organic compound for the treatment of hypertension Download PDF

Info

Publication number
WO2014045072A3
WO2014045072A3 PCT/HU2013/000096 HU2013000096W WO2014045072A3 WO 2014045072 A3 WO2014045072 A3 WO 2014045072A3 HU 2013000096 W HU2013000096 W HU 2013000096W WO 2014045072 A3 WO2014045072 A3 WO 2014045072A3
Authority
WO
WIPO (PCT)
Prior art keywords
deuterium
depleted
organic compound
ddw
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/HU2013/000096
Other languages
French (fr)
Other versions
WO2014045072A2 (en
Inventor
Gábor SOMLYAI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyd Rakkutato Es Gyogyszerfejleszto Kft
Original Assignee
Hyd Rakkutato Es Gyogyszerfejleszto Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyd Rakkutato Es Gyogyszerfejleszto Kft filed Critical Hyd Rakkutato Es Gyogyszerfejleszto Kft
Publication of WO2014045072A2 publication Critical patent/WO2014045072A2/en
Publication of WO2014045072A3 publication Critical patent/WO2014045072A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The main subject of the invention is a pharmaceutical composition comprising deuterium depleted water (DDW) and/or deuterium-depleted organic compound (DDOC) for use as hypertensive agent, wherein the D-content of the DDW or DDOC is 0.01 to 135ppm, and optionally the composition comprises auxiliary materials and optionally the composition comprises other known antihypertensive agent. Another important subject of the invention is an aqueous pharmaceutical composition for use as antihypertensive agent, where the aqueous component of the composition is deuterium depleted water (DDW), wherein the D-content of the DDW is 0.01 to 135 ppm.
PCT/HU2013/000096 2012-09-21 2013-09-23 Pharmaceutical compositions for the treatment of hypertension Ceased WO2014045072A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1200552A HUP1200552A2 (en) 2012-09-21 2012-09-21 Pharmaceutical compositions for the treatment of high blood pressure
HUP1200552 2012-09-21

Publications (2)

Publication Number Publication Date
WO2014045072A2 WO2014045072A2 (en) 2014-03-27
WO2014045072A3 true WO2014045072A3 (en) 2014-08-07

Family

ID=89990887

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/HU2013/000096 Ceased WO2014045072A2 (en) 2012-09-21 2013-09-23 Pharmaceutical compositions for the treatment of hypertension

Country Status (2)

Country Link
HU (1) HUP1200552A2 (en)
WO (1) WO2014045072A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019174659A1 (en) 2018-03-15 2019-09-19 Karl Bau Gmbh Method and assembly for producing water having reduced deuterium content
CA3162366C (en) * 2019-12-20 2023-03-14 Peter Novak Composition and method for the treatment of type i diabetes

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007069934A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method of treating metabolic syndrome
US20080118463A1 (en) * 2005-03-11 2008-05-22 Igor Anatolievich Pomytkin Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof
JP2010265249A (en) * 2009-05-13 2010-11-25 Internatl Scient:Kk Prevention, treatment and rejuvenation, and anti-aging methods for intractable diseases such as cancer by instilling deuterium-depleted water (Super Light Water, DDWATER (registered trademark)).
WO2012004620A2 (en) * 2010-07-08 2012-01-12 Hyd Rákkutató És Gyógyszerfejlesztő Kft. Use of deuterium depleted water for the treatment of insulin resistance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208084B (en) 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
HU209787B (en) 1992-09-24 1994-11-28 X Byo Elelmiszeripari Es Keres Process for producing food-compositions of diminished deuterium-content
HU226984B1 (en) 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080118463A1 (en) * 2005-03-11 2008-05-22 Igor Anatolievich Pomytkin Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof
WO2007069934A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method of treating metabolic syndrome
JP2010265249A (en) * 2009-05-13 2010-11-25 Internatl Scient:Kk Prevention, treatment and rejuvenation, and anti-aging methods for intractable diseases such as cancer by instilling deuterium-depleted water (Super Light Water, DDWATER (registered trademark)).
WO2012004620A2 (en) * 2010-07-08 2012-01-12 Hyd Rákkutató És Gyógyszerfejlesztő Kft. Use of deuterium depleted water for the treatment of insulin resistance

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
"Light Water: Russian scientists developed and began to produce live water", 26 February 2007 (2007-02-26), XP002719437, Retrieved from the Internet <URL:http://biogenesislab.blogspot.nl/2007/02/light-water-russian-scientists.html> [retrieved on 20140129] *
"Preventa: Frequently Asked Questions: Is it possible to experience other favourable physiological effect?", 17 May 2008 (2008-05-17), XP002719387, Retrieved from the Internet <URL:http://web.archive.org/web/20080517202312/http://www.preventa.org/gyik.php> [retrieved on 20140115] *
"Preventa-105", 8 May 2008 (2008-05-08), XP002719391, Retrieved from the Internet <URL:http://web.archive.org/web/20080508030741/http://www.preventa.org/termekeink_preventa105.php> [retrieved on 20140129] *
"Preventa-125", 8 May 2008 (2008-05-08), XP002719390, Retrieved from the Internet <URL:http://web.archive.org/web/20080508025432/http://www.preventa.org/termekeink_preventa125.php> [retrieved on 20140115] *
"Preventa-85", 8 May 2008 (2008-05-08), XP002719392, Retrieved from the Internet <URL:http://web.archive.org/web/20080508034613/http://www.preventa.org/termekeink_preventa85.php> [retrieved on 20140129] *
12 January 2011 (2011-01-12), XP002719438, Retrieved from the Internet <URL:http://web.archive.org/web/20110112023822/http://www.bradolinegroup.com/deuterium.html> [retrieved on 20140115] *
CHERRY COAD: "Physiological Effects of Deuterium Depletion for Health Enhancement", SHORT FEATURES AND BRIEF TAKES ISSUE 205, April 2013 (2013-04-01), XP002719388, Retrieved from the Internet <URL:http://www.positivehealth.com/article/product-news/short-features-and-brief-takes-issue-205> [retrieved on 20140129] *
DATABASE WPI Week 201079, Derwent World Patents Index; AN 2010-P41203, XP002719389 *
RAO G: "Insulin resistance syndrome", AMERICAN FAMILY PHYSICIAN, AMERICAN ACADEMY OF FAMILY PHYSICIANS, US, vol. 63, no. 6, 15 March 2001 (2001-03-15), pages 1159 - 1163, XP002258791 *

Also Published As

Publication number Publication date
HUP1200552A2 (en) 2014-04-28
WO2014045072A2 (en) 2014-03-27

Similar Documents

Publication Publication Date Title
WO2011073279A3 (en) Cosmetic treatment method involving a compound capable of condensing in situ
JOP20180103A1 (en) Pharmaceutical composition
EA201001847A1 (en) COMPOUNDS AND COMPOSITIONS APPLICABLE FOR THE TREATMENT OF MALARIA
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
WO2011141110A3 (en) Photo-stabilizing agents
MY181898A (en) Heterocyclic compounds and uses thereof
WO2012065019A3 (en) Combination comprising pyridopyrimidinone inhibitors of pi3k alpha
WO2011153157A3 (en) Benzoquinolone inhibitors of vmat2
EP2694489A4 (en) THIADIAZINE DIOXIDE COMPOUNDS CONDENSED WITH C5-C6 OXACYCLIC DERIVATIVES AS BACE INHIBITORS, COMPOSITIONS, AND USE
WO2009037061A3 (en) Use of hydrophobin polypeptides as penetration enhancers
EA201270216A1 (en) PHARMACEUTICAL COMPOSITION
WO2012078902A3 (en) Proteostasis regulators
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
EA201101194A1 (en) APPLICATION OF ROSUVASTATIN LACTOL AS A MEDICINE PREPARATION
EA201270256A1 (en) DERIVATIVES OF T1-SUBSTITUTED 5-FLUOR-2-OXOPYRIMIDINON-1 (2H) -KARBOXAMID
CL2014000849A1 (en) Compounds derived from substituted benzylindazoles, bub1 kinase inhibitors; manufacturing procedure; pharmaceutical composition; pharmaceutical combination; and its use in the treatment of hyperproliferative diseases.
WO2010027424A3 (en) 9-substituted phenanthrene based tylophorine derivatives
CL2014001861A1 (en) Compounds derived from benzyl sulfonamide, mogat-2 inhibitors; crystalline compound; pharmaceutical composition; and its use in the treatment of hypertriglyceridemia.
EA201590364A1 (en) APPLICATION OF AIRWAY PERSON, HIS SALTS AND CRYSTALLINE FORMS AND COMPOSITIONS, ITS CONTAINING, FOR THE TREATMENT OF ZUD
EA201201623A1 (en) TREATMENT OF DIABETES TYPE 2
BR112013005609A2 (en) compound of formula (i), composition, use of a compound and new compounds, processes, method and uses
WO2012017321A3 (en) Treatment for dyslipidemia
WO2014164648A3 (en) Solid state forms of a quinazoline derivative and its use as a braf inhibitor
WO2012170098A3 (en) Arbovirus inhibitors and uses thereof
GB201020397D0 (en) Compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13812050

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13812050

Country of ref document: EP

Kind code of ref document: A2